Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dolocare Flex is a nutraceutical and food supplement developed by Procare Health for the management of joint pain and osteoarthritis. The product features a bio-optimized formulation of curcumin, derived from turmeric (*Curcuma longa* root), which is designed to enhance solubility and bioavailability compared to standard turmeric powders. Curcumin acts as an anti-inflammatory agent by targeting multiple molecular pathways involved in joint degradation and pain, including the inhibition of pro-inflammatory mediators. Clinical evidence supports its use in reducing joint pain and the consumption of non-steroidal anti-inflammatory drugs (NSAIDs) or analgesics, thereby improving the quality of life for patients with osteoarthritis across various joint locations such as the knee, hip, and spine. It is formulated as a gluten-free, lactose-free, and sugar-free oral capsule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Dolocare Flex.